NCT03134846 - Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 16, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions

Head and Neck Squamous Cell CarcinomaMargin Assessment

Interventions

DRUG

Cetuximab-IRDye800CW

Pre-operatively administration of Cetuximab-IRDye800CW for intra operative margin assessment using a fluorescent antibody-based optical tracer

Trial Locations (1)

RECRUITING

University Medical Center Groningen, Groningen